U
AMED

UBS’s Amedisys AMED Stock Holding History

UBS’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$10K Buy
500
+100
+25% +$1.93K ﹤0.01% 8809
2014
Q2 		$7K Sell
400
-1,300
-76% -$18.4K ﹤0.01% 9191
2014
Q1 		$25K Buy
1,700
+800
+89% +$12.3K ﹤0.01% 7781
2013
Q4 		$13K Sell
900
-100
-10% -$1.61K ﹤0.01% 8679
2013
Q3 		$17K Sell
1,000
-3,800
-79% -$56.4K ﹤0.01% 8240
2013
Q2 		$56K Buy
+4,800
New +$55K ﹤0.01% 6591

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS's AMED Position: Q3 2014 in Review

UBS increased its Amedisys (AMED) stake by 10% in Q3 2014, buying an estimated $106K and bringing the position to 58,448 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3429.

UBS first reported a position in AMED in Q2 2013 and has held it in 6 quarters since. 125 funds tracked by Wall St. Rank hold AMED as of Q3 2014.

  • UBS held 58,448 shares of Amedisys worth $1.18M as of Q3 2014.
  • UBS bought 5,480 Amedisys shares in Q3 2014, an estimated $106K.
  • Amedisys made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3429 holding.
  • UBS first reported a position in Amedisys in Q2 2013 and has held it in 6 quarters since.
  • 125 funds tracked by Wall St. Rank held Amedisys as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.